Prophylactic total pancreatectomy in individuals at high risk of pancreatic ductal adenocarcinoma (PROPAN): systematic review and shared decision-making programme using decision tables

United European Gastroenterol J. 2020 Oct;8(8):865-877. doi: 10.1177/2050640620945534. Epub 2020 Jul 23.

Abstract

Background: Individuals with a very high lifetime risk of developing pancreatic ductal adenocarcinoma; for example, hereditary pancreatitis and main-duct or mixed-type intraductal papillary mucinous neoplasm, may wish to discuss prophylactic total pancreatectomy but strategies to do so are lacking.

Objective: To develop a shared decision-making programme for prophylactic total pancreatectomy using decision tables.

Methods: Focus group meetings with patients were used to identify relevant questions. Systematic reviews were performed to answer these questions.

Results: The first tables included hereditary pancreatitis and main-duct or mixed-type intraductal papillary mucinous neoplasm. No studies focused on prophylactic total pancreatectomy in these groups. In 52 studies (3570 patients), major morbidity after total pancreatectomy was 25% and 30-day mortality was 6%. After minimally invasive total pancreatectomy (seven studies, 35 patients) this was, respectively, 13% and 0%. Exocrine insufficiency-related symptoms occurred in 33%. Quality of life after total pancreatectomy was slightly lower compared with the general population.

Conclusion: The decision tables can be helpful for discussing prophylactic total pancreatectomy with individuals at high risk of pancreatic ductal adenocarcinoma.

Keywords: Pancreatic ductal adenocarcinoma; cancer risk; diabetes mellitus; hereditary pancreatitis; intraductal papillary mucinous neoplasm; mutation; prophylactic total pancreatectomy.

Publication types

  • Research Support, Non-U.S. Gov't